NDC 0409-0120

Daptomycin

Daptomycin

Daptomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Daptomycin.

Product ID0409-0120_38e8f402-3c58-4173-a589-b38049e837d8
NDC0409-0120
Product TypeHuman Prescription Drug
Proprietary NameDaptomycin
Generic NameDaptomycin
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2021-08-02
Marketing CategoryNDA /
Application NumberNDA210282
Labeler NameHospira, Inc.
Substance NameDAPTOMYCIN
Active Ingredient Strength350 mg/7mL
Pharm ClassesLipopeptide Antibacterial [EPC], Lipopeptides [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0409-0120-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0120-01) > 7 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2021-08-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Daptomycin" or generic name "Daptomycin"

NDCBrand NameGeneric Name
0143-9378DaptomycinDaptomycin
0409-0106DaptomycinDAPTOMYCIN
0409-0120DaptomycinDAPTOMYCIN
0409-0122DaptomycinDAPTOMYCIN
0409-2757DaptomycinDAPTOMYCIN
0409-5933DaptomycinDaptomycin
0703-0125DaptomycinDaptomycin
0781-3295daptomycindaptomycin
16714-892DaptomycinDaptomycin
16729-434DaptomycinDaptomycin
16729-435DAPTOMYCINDaptomycin
25021-174daptomycindaptomycin
25021-179DaptomycinDaptomycin
70594-034DaptomycinDaptomycin
70594-053DaptomycinDaptomycin
63323-871DaptomycinDaptomycin
63323-371DaptomycinDaptomycin
67457-813daptomycindaptomycin
43598-413DaptomycinDaptomycin
68001-376DaptomycinDaptomycin
63323-585DaptomycinDaptomycin
71839-107daptomycindaptomycin
57884-3151DaptomycinDaptomycin
69097-807DaptomycinDaptomycin
72572-102DaptomycinDaptomycin
72572-100DaptomycinDaptomycin
45932-0039DaptomycinDaptomycin
71288-018DAPTOMYCINDAPTOMYCIN
76233-091DaptomycinDaptomycin
31722-102DaptomycinDaptomycin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.